Sildenafil for the treatment of preeclampsia

Hypertension in Pregnancy

Volumn 29, Issue 2, 2010, Pages 248-250

  Downing, John ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPHEDRINE; PHENYLEPHRINE; PLACEBO; SILDENAFIL; TADALAFIL;

CLINICAL TRIAL; DELIVERY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; ENDOTHELIAL DYSFUNCTION; EPIGASTRIC PAIN; FETUS CIRCULATION; FETUS OUTCOME; GESTATIONAL AGE; HEADACHE; HUMAN; HYPOTENSION; INCIDENCE; INTRAUTERINE GROWTH RETARDATION; LETTER; LOW BIRTH WEIGHT; MATERNAL CARE; MEDICAL PRACTICE; MENTAL DEFICIENCY; MORBIDITY; NONHUMAN; OLIGURIA; PERINATAL MORTALITY; PHYSICAL DISABILITY; PLACENTA CIRCULATION; PREECLAMPSIA; PREGNANT WOMAN; PREMATURITY; PROGNOSIS; PROTEINURIA; SECOND TRIMESTER PREGNANCY; SHEEP; SOUTH AFRICA; SPINAL ANESTHESIA; SURVIVOR; SYSTOLIC BLOOD PRESSURE; VOMITING;

FEMALE; HUMANS; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; PRE-ECLAMPSIA; PREGNANCY; PURINES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SULFONES;

EID: 77950810248     PISSN: 10641955     EISSN: 15256065     Source Type: Journal    
DOI: 10.3109/10641951003634766     Document Type: Letter

References (9)

1. Samangaya RA, Mires G, Shennan A, Skillern L, Howe D, McLeod A, Baker PN. A randomised, double-blinded, placebo-controlled study of the phosphodiesterase type 5 inhibitor sildenafil for the treatment of preeclampsia. Hypertens Pregnancy 2009; 28:369-382.
2. Downing JW, Ramasubramanian R, Johnson RF, Minzter BH, Paschall RL, Sundell HW, Engelhardt B, Lewis R. Hypothesis: selective phosphodiesterase-5 inhibition improves outcome in preeclampsia. Med Hypoth 2004; 63:1057-1064. (Pubitemid 39422408)
3. Miller SL, Loose JM, Jenkin G, Wallace EM. The effects of sildenafil citrate (Viagra) on uterine blood flow and well being in the intrauterine growth-restricted fetus. Am J Obstet Gynecol 2009; 200:102.e1-102.e7.
4. Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 2003; 102:181-192. (Pubitemid 36792143)
5. Greiss FC, Crandell DL. Therapy for hypotension induced by spinal anesthesia during pregnancy: observations in gravid ewes. JAMA 1965; 191:793-796.
6. James FM III, Greiss Jr FC, Kemp RA. An evaluation of vasopressor therapy for maternal hypotension during spinal anesthesia. Anesthesiology 1970; 33:25-34.
7. Labartino L, Mojdehi E, Mauro AL. Management of hypotension following spinal anesthesia for cesarean section. Anesth Analg 1966; 45:179-182.
8. Ngan Kee WD, Khaw KS, Ng FF. Prevention of hypotension during spinal anesthesia for cesarean delivery: an effective technique using combination phenylephrine infusion and crystalloid cohydration. Anesthesiology 2005; 103:744-750.
9. Romero R, Nien JK, Espinoza J, Todem D, Fu W, Chung H, Kusanovic JP, Gotsch F, Erez O, Mazaki-tovi S, Gomez R, Edwin S, Chaiworapongsa T, Levine RJ, Karumanchi A. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble VEGF receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a smallfor- gestational-age neonate. J Matern Fetal Neonatal Med 2008; 21:9-23.